文献速递神经核医学

[18F]PR04.MZ PET/CT 评估帕金森病黑质纹状体神经元完整性

[18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该研究纳入18名健康对照、19例早期帕金森病(Hoehn-Yahr I-II)和13例中晚期帕金森病(Hoehn-Yahr III-IV)患者,注射5.16 ± 1.03 mCi(191 ± 38 MBq)[18F]PR04.MZ后60-90分钟行静态PET/CT,计算尾状核、前壳核、后壳核和黑质致密部的特异性结合比(SBR)。结果显示[18F]PR04.MZ在壳核、尾状核和黑质致密部有高特异性摄取,帕金森病各区域SBR降低35%-89%(P < 0.001),降低模式为后壳核>前壳核>黑质致密部>尾状核,对侧后壳核受累最重。

要点

  • [18F]PR04.MZ PET/CT对帕金森病黑质纹状体多巴胺能缺陷高度敏感。
  • 帕金森病SBR降低模式为后壳核>前壳核>黑质致密部>尾状核。
  • 对侧后壳核是帕金森病受累最严重的区域。

核心结论

  • [18F]PR04.MZ PET/CT是检测帕金森病黑质纹状体通路多巴胺能缺陷的高度敏感成像方法。

研究设计与样本

  • 研究纳入18名健康受试者、19例早期帕金森病(Hoehn-Yahr I-II)和13例中晚期帕金森病(Hoehn-Yahr III-IV)患者。
  • 注射5.16 ± 1.03 mCi(191 ± 38 MBq)[18F]PR04.MZ后60至90分钟行静态PET/CT扫描。
  • 计算尾状核、前壳核、后壳核和黑质致密部的特异性结合比(SBR),组间比较并与临床评分相关。

主要发现

  • [18F]PR04.MZ在壳核、尾状核和黑质致密部显示非常高且特异的摄取,其他脑区非特异性结合很低。
  • 对照组SBR值在壳核、尾状核和黑质致密部分别为22.3 ± 4.1、19.1 ± 3.5和5.4 ± 1.2。
  • 早期和中晚期帕金森病所有区域SBR值降低35%至89%(P < 0.001)。
  • SBR降低模式为后壳核>前壳核>黑质致密部>尾状核,对侧后壳核受累最严重。
  • 所有帕金森病患者可见头尾侧耗竭梯度,且进展与运动表现相关。

临床怎么用

  • 可用于帕金森病与特发性震颤的鉴别诊断,并评估黑质纹状体多巴胺能缺陷程度。

局限性

  • 本研究为概念验证性研究,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Degeneration of dopaminergic, nigrostriatal neurons is the hallmark of Parkinson disease (PD), and PET quantification of dopamine transporters is a widely accepted method for differential diagnosis between idiopathic PD and essential tremor. [18F]PR04.MZ is a new PET tracer with excellent imaging properties allowing for precise quantification of striatal and extrastriatal dopamine transporter. Here we describe our initial experience with [18F]PR04.MZ PET/CT in a larger cohort of healthy controls and PD patients as a proof-of-concept study for this tracer. METHODS: Eighteen healthy subjects, 19 early PD patients (Hoehn-Yahr I-II), and 13 moderate-advanced PD patients (Hoehn-Yahr III-IV) underwent static PET/CT scans 60 to 90 minutes after injection of 5.16 ± 1.03 mCi (191 ± 38 MBq) [18F]PR04.MZ. Specific binding ratios (SBRs) were calculated for caudate nucleus, anterior putamen, posterior putamen, substantia nigra (SNpc), compared between different groups and correlated with clinical ratings. RESULTS: [18F]PR04.MZ showed very high and specific uptake in the putamen, caudate, and substantia nigra pars compacta and very low nonspecific binding in other brain regions, and SBR values for the control group were 22.3 ± 4.1, 19.1 ± 3.5, and 5.4 ± 1.2, respectively. A reduction of SBR values was observed in all regions and in both initial and moderate PD, ranging from 35% to 89% (P < 0.001). The observed pattern of reduction was posterior putamen > anterior putamen > substantia nigra pars compacta > caudate, with contralateral posterior putamen being the most affected region. Rostrocaudal depletion gradient was evident in all PD patients and progression correlated with motor manifestations. CONCLUSIONS: [18F]PR04.MZ PET/CT is a highly sensitive imaging modality for the detection of dopaminergic deficit in nigrostriatal pathways in PD.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Juri C, Kramer V, Riss PJ, et al. [18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease. Clin Nucl Med. 2021. PMID: 33323728. doi:10.1097/RLU.0000000000003430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。